MedTrace Logo

The CareWell-programme for Community-dwelling Frail Elderly Persons.

NCT01499797 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 536

Last updated 2013-06-07

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of the CareWell-programme on overall functioning of community-dwelling frail elderly persons. Furthermore, the total costs and the cost-effectiveness of the CareWell-programme, in comparison with regular medical care, will be studied.

Conditions

  • Overall Functioning
  • Incremental Cost-effectiveness Ratio

Interventions

OTHER

The CareWell programme

The CareWell programme contains the following components: * multidisciplinary primary care teams * working with proactive care plans integrating cure, care and welfare * advanced care planning (e.g. recording limitations of treatment, non-resuscitation decisions) * medication review * case-management * guidelines for consultation of in-hospital geriatric experts * guidelines for transfers from primary care to home-based facilities and hospital and back * practice guidelines for management of common geriatric conditions

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • Dutch Healthcare Authority

    collaborator UNKNOWN

  • Health insurances CZ

    collaborator UNKNOWN

  • Health insurances UVIT

    collaborator UNKNOWN

  • City of Nijmegen

    collaborator UNKNOWN

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Raymond Koopmans, Professor · Radboud University Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-01-31
Completion
2013-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01499797 on ClinicalTrials.gov